Anti-TPRN monoclonal antibody

Pre-made anti-TPRN monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TPRN/TPRN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2775-Ab-1/ GM-Tg-hg-IP2775-Ab-2Anti-Human TPRN monoclonal antibodyHuman
GM-Tg-rg-IP2775-Ab-1/ GM-Tg-rg-IP2775-Ab-2Anti-Rat TPRN monoclonal antibodyRat
GM-Tg-mg-IP2775-Ab-1/ GM-Tg-mg-IP2775-Ab-2Anti-Mouse TPRN monoclonal antibodyMouse
GM-Tg-cynog-IP2775-Ab-1/ GM-Tg-cynog-IP2775-Ab-2Anti-Cynomolgus/ Rhesus macaque TPRN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2775-Ab-1/ GM-Tg-felg-IP2775-Ab-2Anti-Feline TPRN monoclonal antibodyFeline
GM-Tg-cang-IP2775-Ab-1/ GM-Tg-cang-IP2775-Ab-2Anti-Canine TPRN monoclonal antibodyCanine
GM-Tg-bovg-IP2775-Ab-1/ GM-Tg-bovg-IP2775-Ab-2Anti-Bovine TPRN monoclonal antibodyBovine
GM-Tg-equg-IP2775-Ab-1/ GM-Tg-equg-IP2775-Ab-2Anti-Equine TPRN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2775-Ab-1/ GM-Tg-hg-IP2775-Ab-2; GM-Tg-rg-IP2775-Ab-1/ GM-Tg-rg-IP2775-Ab-2;
GM-Tg-mg-IP2775-Ab-1/ GM-Tg-mg-IP2775-Ab-2; GM-Tg-cynog-IP2775-Ab-1/ GM-Tg-cynog-IP2775-Ab-2;
GM-Tg-felg-IP2775-Ab-1/ GM-Tg-felg-IP2775-Ab-2; GM-Tg-cang-IP2775-Ab-1/ GM-Tg-cang-IP2775-Ab-2;
GM-Tg-bovg-IP2775-Ab-1/ GM-Tg-bovg-IP2775-Ab-2; GM-Tg-equg-IP2775-Ab-1/ GM-Tg-equg-IP2775-Ab-2
Products NameAnti-TPRN monoclonal antibody
Formatmab
Target NameTPRN
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TPRN monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2775-Ag-1Recombinant multi-species TPRN/ C9orf75/ DFNB79 protein


    Target information

    Target IDGM-IP2775
    Target NameTPRN
    Gene ID286262,97031,499749,721581,119873341,101083303,100125320,100146716
    Gene Symbol and SynonymsC430004E15Rik,C9orf75,DFNB79,TPRN
    Uniprot AccessionQ4KMQ1,Q5XHX2
    Uniprot Entry NameTPRN_HUMAN,TPRN_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176058
    Target ClassificationN/A

    The target: TPRN, gene name: TPRN, also named as C9orf75, DFNB79. This locus encodes a sensory epithelial protein. It was defined by linkage analysis in three Pakistani families to lie between D9S1818 (centromeric) and D9SH6 (telomeric). Mutations at this locus have been associated with autosomal recessive deafness. [provided by RefSeq, Oct 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.